ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis (2014)
Velosa, A. Pereira; Paiva, M. A.; Andrade, P. C.; Rangel, M. P.; Christmann, R. B.; Eher, E. M.; Fernezlian, S. M.; Parra, E. R.; Teodoro, W. R.; Capelozzi, V. L.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM
Subjects: IMUNOLOGIA CELULAR, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VELOSA, A. Pereira et al. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8196. Acesso em: 03 jun. 2024. , 2014
APA
Velosa, A. P., Paiva, M. A., Andrade, P. C., Rangel, M. P., Christmann, R. B., Eher, E. M., et al. (2014). Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8196
NLM
Velosa AP, Paiva MA, Andrade PC, Rangel MP, Christmann RB, Eher EM, Fernezlian SM, Parra ER, Teodoro WR, Capelozzi VL. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27-S28.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Vancouver
Velosa AP, Paiva MA, Andrade PC, Rangel MP, Christmann RB, Eher EM, Fernezlian SM, Parra ER, Teodoro WR, Capelozzi VL. Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27-S28.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Trabalho de evento-resumo periodico
Systemic sclerosis-related auto-antibodies are markers of new clinical associations in a co-hort of 328 brazilian patients (2014)
Silva, C. M.; Bortoluzzo, A. B.; Viana, V. S.; Pasoto, S. G.; Leon, E. P.; Bonfá, E.; Sampaio-Barros, P. D.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM
Subjects: AUTOANTICORPOS, DOENÇAS AUTOIMUNES, BRASILEIROS, ESTUDOS DE COORTES, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, C. M. et al. Systemic sclerosis-related auto-antibodies are markers of new clinical associations in a co-hort of 328 brazilian patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 03 jun. 2024. , 2014
APA
Silva, C. M., Bortoluzzo, A. B., Viana, V. S., Pasoto, S. G., Leon, E. P., Bonfá, E., & Sampaio-Barros, P. D. (2014). Systemic sclerosis-related auto-antibodies are markers of new clinical associations in a co-hort of 328 brazilian patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Silva CM, Bortoluzzo AB, Viana VS, Pasoto SG, Leon EP, Bonfá E, Sampaio-Barros PD. Systemic sclerosis-related auto-antibodies are markers of new clinical associations in a co-hort of 328 brazilian patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-120.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Silva CM, Bortoluzzo AB, Viana VS, Pasoto SG, Leon EP, Bonfá E, Sampaio-Barros PD. Systemic sclerosis-related auto-antibodies are markers of new clinical associations in a co-hort of 328 brazilian patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-120.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Trabalho de evento-resumo periodico
Clinical and serological comparative analysis of systemic sclerosis with or without overlap syndromes in a large Brazilian cohort (2014)
Silva, C. M.; Pasoto, S. G.; Viana, V. S.; Seguro, L. P. C.; Andrade, D. C. O.; Bonfá, E.; Sampaio-Barros, P. D.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM
Subjects: TESTES SOROLÓGICOS, DOENÇAS AUTOIMUNES, BRASILEIROS, ESTUDOS DE COORTES, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, C. M. et al. Clinical and serological comparative analysis of systemic sclerosis with or without overlap syndromes in a large Brazilian cohort. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 03 jun. 2024. , 2014
APA
Silva, C. M., Pasoto, S. G., Viana, V. S., Seguro, L. P. C., Andrade, D. C. O., Bonfá, E., & Sampaio-Barros, P. D. (2014). Clinical and serological comparative analysis of systemic sclerosis with or without overlap syndromes in a large Brazilian cohort. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Silva CM, Pasoto SG, Viana VS, Seguro LPC, Andrade DCO, Bonfá E, Sampaio-Barros PD. Clinical and serological comparative analysis of systemic sclerosis with or without overlap syndromes in a large Brazilian cohort [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-116-S117.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Silva CM, Pasoto SG, Viana VS, Seguro LPC, Andrade DCO, Bonfá E, Sampaio-Barros PD. Clinical and serological comparative analysis of systemic sclerosis with or without overlap syndromes in a large Brazilian cohort [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-116-S117.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Trabalho de evento-resumo periodico
Anti-endothelial cell antibodies as biomarker of severe vascular manifestations in systemic sclerosis (2014)
Vahos, C. Muñoz; Goldenstein-Schainberg, C.; Viana, V. S.; Carrasco, S.; Leon, E. P.; Bonfa, E.; Vasquez, G.; Sampaio-Barros, P. D.; Ferriani, Virgínia Paes Leme
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM
Subjects: ANTICORPOS, BIOMARCADORES, SISTÊMICO ESCLERODERMA, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAHOS, C. Muñoz et al. Anti-endothelial cell antibodies as biomarker of severe vascular manifestations in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8196. Acesso em: 03 jun. 2024. , 2014
APA
Vahos, C. M., Goldenstein-Schainberg, C., Viana, V. S., Carrasco, S., Leon, E. P., Bonfa, E., et al. (2014). Anti-endothelial cell antibodies as biomarker of severe vascular manifestations in systemic sclerosis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8196
NLM
Vahos CM, Goldenstein-Schainberg C, Viana VS, Carrasco S, Leon EP, Bonfa E, Vasquez G, Sampaio-Barros PD, Ferriani VPL. Anti-endothelial cell antibodies as biomarker of severe vascular manifestations in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-24.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Vancouver
Vahos CM, Goldenstein-Schainberg C, Viana VS, Carrasco S, Leon EP, Bonfa E, Vasquez G, Sampaio-Barros PD, Ferriani VPL. Anti-endothelial cell antibodies as biomarker of severe vascular manifestations in systemic sclerosis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-24.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Trabalho de evento-resumo periodico
Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis (2014)
Martins, V.; Lopes, D. B.; Antunes, M.; Velosa, A. P. P; Teodoro, W. R; Parra, E. R.; Capelozzi, V. L.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidade: FM
Subjects: FEBRE PULMONAR, COLÁGENO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, V. et al. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8196. Acesso em: 03 jun. 2024. , 2014
APA
Martins, V., Lopes, D. B., Antunes, M., Velosa, A. P. P., Teodoro, W. R., Parra, E. R., & Capelozzi, V. L. (2014). Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8196
NLM
Martins V, Lopes DB, Antunes M, Velosa APP, Teodoro WR, Parra ER, Capelozzi VL. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Vancouver
Martins V, Lopes DB, Antunes M, Velosa APP, Teodoro WR, Parra ER, Capelozzi VL. Pulmonary fibrosis induced by bleomycin is driven by high collagen V and TGF- synthesis [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-27.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8196
Trabalho de evento-resumo periodico
Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients (2014)
Morais, J.; Martin, P.; Velosa, A. P. P.; Andrade, P. C.; Cruz, I. B.; Miracca, E. C.; Barrence, F. A. C.; Carrasco, S.; Goldeinstein-Schainberg, C.; Nagai, M. A.; Parra, E. R.; Capelozzi, V. L.; Teodoro, W. R.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidades: FM, ICB
Subjects: IMUNOLOGIA, EXPRESÃO GÊNICA, COLÁGENO, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 03 jun. 2024. , 2014
APA
Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 jun. 03 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects